Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving [alpha]1-blocker treatment: a multi-centre, prospective, randomised study
To evaluate the efficacy and safety of imidafenacin (IM), a novel short half-life anticholinergic, as add-on therapy for male LUTS with nocturia and nocturnal polyuria. This multicenter, prospective, randomized, open-labelled study was conducted and involved men who had frequency, urgency, and noctu...
Gespeichert in:
Veröffentlicht in: | World journal of urology 2015-05, Vol.33 (5), p.659 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!